Top US trade official blasts German streaming quota plan

The clash comes barely a week after Brussels moved to implement the EU-U.S. Turnberry trade pact.

POLITICO
The winners and losers from the UK’s trade deal with the Gulf

As details of the deal trickle through, POLITICO has identified the sectors that look most likely to benefit as well as those who appear to be missing out.

POLITICO
China says preliminary agreement reached with US to lower some tariffs

The two sides “agreed to promote two-way trade, including in agricultural products, through arrangements such as mutual tariff reductions on a range of products,” the commerce ministry in Beijing said.

POLITICO
Merz’s strategy for dealing with Trump’s anger: Tell him he’s right

After a perilous blowup with Washington, the chancellor is falling back on the familiar tactic of saying things the U.S. president likes to hear.

POLITICO
EU trade chief to meet with Trump’s top trade official as tensions spike

Maroš Šefčovič to meet Jamieson Greer on the eve of a G7 trade ministerial in Paris, as transatlantic trade tensions spike again.

POLITICO
Trump threatens to raise tariffs on EU automobiles to 25 percent

The social media post comes amid simmering trade tensions between the EU and U.S. on the terms of the trade agreement they reached last year.

Politico
The EU-Mercosur deal takes effect — but the fight over it goes on

The trade accord with the South American bloc will boost exports of cars and Champagne, but political wrangling over it persists.

POLITICO
White House confirms 100% pharmaceutical tariff includes broad exemptions allowing companies to secure 0% rate through U.S. facility investments and MFN pricing agreements, with South Korea, Japan, and European firms exempt under existing trade deals
#YonhapInfomax #PharmaceuticalTariffs #TrumpAdministration #MostFavoredNation #TradeAgreements #AstraZeneca #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113604
US Imposes 100% Tariff on Pharmaceuticals, But '0% Rate Possible'

White House confirms 100% pharmaceutical tariff includes broad exemptions allowing companies to secure 0% rate through U.S. facility investments and MFN pricing agreements, with South Korea, Japan, and European firms exempt under existing trade deals

Yonhap Infomax

RE: https://mstdn.ca/@AlisonCreekside/116262358371469034

* Quelle surprise.* #GinaRinehart pulls a lever that #billionaires forced many countries to include in #TradeAgreements: #ISDS.

Don't know why the Tyee thinks this is rare/unusual/'little known'. Investor-State Dispute Settlements are common. Imo they are added to agreements because #WTO courts are too fair. They allow rich people to sue every taxpayer in a country, and win because they are rich, not because they have merit.

Rinehart: https://static.independent.co.uk/2024/05/16/10/nga-1.jpg

ISDS news: https://noai.duckduckgo.com/?q=investor-state+dispute+settlement+isds&iar=news&noai=1